Trends for prevalence and incidence of resistant hypertension: population based cohort study in the UK 1995-2015.

Sarah-Jo Sinnott, Liam Smeeth, Elizabeth Williamson, Ian J Douglas
{"title":"Trends for prevalence and incidence of resistant hypertension: population based cohort study in the UK 1995-2015.","authors":"Sarah-Jo Sinnott, Liam Smeeth, Elizabeth Williamson, Ian J Douglas","doi":"10.1136/bmj.j3984","DOIUrl":null,"url":null,"abstract":"<p><p><b>Objective</b> To estimate the incidence and prevalence of resistant hypertension among a UK population treated for hypertension from 1995 to 2015.<b>Design</b> Cohort study.<b>Setting</b> Electronic health records from the UK Clinical Practice Research Datalink in primary care.<b>Participants</b> 1 317 290 users of antihypertensive drugs with a diagnosis of hypertension.<b>Main outcome measures</b> Resistant hypertension was defined as concurrent use of three antihypertensive drugs inclusive of a diuretic, uncontrolled hypertension (≥140/90 mm Hg), and adherence to the prescribed drug regimen, or concurrent use of four antihypertensive drugs inclusive of a diuretic and adherence to the prescribed drug regimen. To determine incidence, the numerator was new cases of resistant hypertension and the denominator was person years of those with treated hypertension and at risk of developing resistant hypertension. To determine prevalence, the numerator was total number of cases with resistant hypertension and the denominator was those with treated hypertension. Prevalence and incidence were age standardised to the 2015 hypertensive population.<b>Results</b> The age standardised incidence of resistant hypertension increased from 0.93 cases per 100 person years (95% confidence interval 0.87 to 1.00) in 1996 to a peak level of 2.07 cases per 100 person years (2.03 to 2.12) in 2004. Incidence then decreased to 0.42 cases per 100 person years (0.40 to 0.44) in 2015. Age standardised prevalence increased from 1.75% (95% confidence interval 1.66% to 1.83%) in 1995 to a peak of 7.76% (7.70% to 7.83%) in 2007. Prevalence then plateaued and subsequently declined to 6.46% (6.38% to 6.54%) in 2015. Compared with patients aged 65-69 years, those aged 80 or more years were more likely to have prevalent resistant hypertension throughout the study period.<b>Conclusions</b> Prevalent resistant hypertension has plateaued and decreased in recent years, consistent with a decrease in incidence from 2004 onwards. Despite this, resistant hypertension is common in the UK hypertensive population. Given the importance of hypertension as a modifiable risk factor for cardiovascular disease, reducing uncontrolled hypertension should remain a population health focus.</p>","PeriodicalId":93911,"journal":{"name":"BMJ (Clinical research ed.)","volume":"358 ","pages":"j3984"},"PeriodicalIF":0.0000,"publicationDate":"2017-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609092/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ (Clinical research ed.)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/bmj.j3984","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective To estimate the incidence and prevalence of resistant hypertension among a UK population treated for hypertension from 1995 to 2015.Design Cohort study.Setting Electronic health records from the UK Clinical Practice Research Datalink in primary care.Participants 1 317 290 users of antihypertensive drugs with a diagnosis of hypertension.Main outcome measures Resistant hypertension was defined as concurrent use of three antihypertensive drugs inclusive of a diuretic, uncontrolled hypertension (≥140/90 mm Hg), and adherence to the prescribed drug regimen, or concurrent use of four antihypertensive drugs inclusive of a diuretic and adherence to the prescribed drug regimen. To determine incidence, the numerator was new cases of resistant hypertension and the denominator was person years of those with treated hypertension and at risk of developing resistant hypertension. To determine prevalence, the numerator was total number of cases with resistant hypertension and the denominator was those with treated hypertension. Prevalence and incidence were age standardised to the 2015 hypertensive population.Results The age standardised incidence of resistant hypertension increased from 0.93 cases per 100 person years (95% confidence interval 0.87 to 1.00) in 1996 to a peak level of 2.07 cases per 100 person years (2.03 to 2.12) in 2004. Incidence then decreased to 0.42 cases per 100 person years (0.40 to 0.44) in 2015. Age standardised prevalence increased from 1.75% (95% confidence interval 1.66% to 1.83%) in 1995 to a peak of 7.76% (7.70% to 7.83%) in 2007. Prevalence then plateaued and subsequently declined to 6.46% (6.38% to 6.54%) in 2015. Compared with patients aged 65-69 years, those aged 80 or more years were more likely to have prevalent resistant hypertension throughout the study period.Conclusions Prevalent resistant hypertension has plateaued and decreased in recent years, consistent with a decrease in incidence from 2004 onwards. Despite this, resistant hypertension is common in the UK hypertensive population. Given the importance of hypertension as a modifiable risk factor for cardiovascular disease, reducing uncontrolled hypertension should remain a population health focus.

Abstract Image

Abstract Image

Abstract Image

顽固性高血压的患病率和发病率趋势:1995-2015年英国基于人群的队列研究
目的评估1995年至2015年英国高血压治疗人群中顽固性高血压的发病率和患病率。设计队列研究。在初级保健中设置英国临床实践研究数据链中的电子健康记录。参与者为1 317 290名诊断为高血压的降压药使用者。顽固性高血压定义为同时使用三种降压药,包括一种利尿剂,未控制的高血压(≥140/90 mm Hg),并坚持处方药物方案,或同时使用四种降压药,包括一种利尿剂,并坚持处方药物方案。为了确定发病率,分子是顽固性高血压的新病例,分母是接受治疗的高血压患者和有发展为顽固性高血压风险的人的年数。为确定患病率,分子为顽固性高血压的总病例数,分母为已治疗高血压的病例数。对2015年高血压人群的患病率和发病率进行年龄标准化。结果顽固性高血压的年龄标准化发病率从1996年的0.93例/ 100人年(95%可信区间0.87 ~ 1.00)上升到2004年的峰值2.07例/ 100人年(95%可信区间2.03 ~ 2.12)。2015年,发病率降至0.42例/ 100人年(0.40 - 0.44)。年龄标准化患病率从1995年的1.75%(95%可信区间1.66% ~ 1.83%)上升到2007年的峰值7.76%(7.70% ~ 7.83%)。患病率随后趋于平稳,随后在2015年下降至6.46%(6.38%至6.54%)。与65-69岁的患者相比,80岁及以上的患者在整个研究期间更有可能出现普遍的顽固性高血压。结论:近年来,顽固性高血压的发病率趋于稳定并有所下降,与2004年以来的发病率下降趋势一致。尽管如此,顽固性高血压在英国高血压人群中很常见。鉴于高血压作为心血管疾病的可改变危险因素的重要性,减少不受控制的高血压仍应是人口健康的重点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信